Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / Ordinary Shares, par value Euro 0.01 per share
-
Shares outstanding
-
78.1M
-
Number of holders
-
164
-
Total 13F shares, excl. options
-
52M
-
Shares change
-
+21.3M
-
Total reported value, excl. options
-
$4.41B
-
Value change
-
+$2.13B
-
Put/Call ratio
-
0.69
-
Number of buys
-
144
-
Number of sells
-
-24
-
Price
-
$84.90
Significant Holders of Abivax S.A. - Ordinary Shares, par value Euro 0.01 per share (ABVX) as of Q3 2025
177 filings reported holding ABVX - Abivax S.A. - Ordinary Shares, par value Euro 0.01 per share as of Q3 2025.
Abivax S.A. - Ordinary Shares, par value Euro 0.01 per share (ABVX) has 164 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 52M shares
of 78.1M outstanding shares and own 66.49% of the company stock.
Largest 10 shareholders include TCG Crossover Management, LLC (7.11M shares), UBS Group AG (4.46M shares), Darwin Global Management, Ltd. (3.16M shares), Point72 Asset Management, L.P. (2.93M shares), Cormorant Asset Management, LP (1.95M shares), Paradigm Biocapital Advisors LP (1.56M shares), MORGAN STANLEY (1.47M shares), Caligan Partners LP (1.45M shares), FMR LLC (1.43M shares), and ADAR1 Capital Management, LLC (1.35M shares).
This table shows the top 164 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.